NeoGenomics to Report Second Quarter 2025 Financial Results on July 29, 2025
NeoGenomics Announces PanTracer Tissue and PanTracer Tissue + HRD Now Available to Support More Informed and Timely Cancer Care
NeoGenomics Appoints Dr. Marjorie Green to Board of Directors
For more information regarding accessibility, please use the following form to contact us
* denotes a required field